Probiotics and antibiotics: why combine them and how to use them correctly?

The combination of probiotics and antibiotics is generating increasing interest among healthcare professionals and consumers concerned about preserving their gut microbiota. While antibiotics represent a major advance in modern medicine and remain indispensable in many situations, their action does not solely target the bacteria responsible for infection. They also influence the gut flora, sometimes creating a transient intestinal imbalance.

In this context, understanding the complementarity between probiotics and antibiotics becomes essential. Live microorganisms, also known as lactic ferments or specific bacterial strains, can contribute to microbiota balance during an antibiotic regimen. This approach is part of a holistic vision of digestive health, consistent with Biocyte's nutricosmetic expertise, the leading French laboratory specializing at the interface of nutrition and cosmetics, renowned for the scientific quality of its formulations.

The combination of probiotic and antibiotic is part of a complementary approach aimed at preserving the balance of the intestinal microbiota throughout an antibiotic regimen, taking into account the complex interactions between anti-infective treatment and the digestive ecosystem.

The intestinal microbiota is a complex ecosystem composed of billions of microorganisms. This dynamic ensemble plays a key role in digestion, nutrient metabolism, and the proper functioning of the immune system. When antibiotic treatment is initiated, its goal is to eliminate pathogenic bacteria responsible for the infection. However, its action can also affect commensal bacteria useful for the balance of the intestinal flora.

Several clinical studies have shown that an antibiotic regimen can temporarily reduce bacterial diversity and alter the composition of the microbiota. This alteration, sometimes referred to as dysbiosis, corresponds to an imbalance between beneficial and opportunistic bacteria. Depending on the molecule used and the duration of treatment, this disturbance can be more or less pronounced.

In this context, the combination of probiotic and antibiotic aims to support this weakened ecosystem. Selected microorganisms can help maintain a more stable intestinal environment, especially when bacterial diversity is transiently reduced.

The intestinal imbalance induced by antibiotic therapy can manifest as various discomforts. Antibiotic-associated diarrhea is one of the most frequently observed effects. It results partly from the modification of the bacterial flora, which alters the fermentation of food substrates and the regulation of transit.

Bloating, abdominal pain, or a feeling of difficult digestion can also appear. These manifestations often indicate temporary dysbiosis. In some people, the decrease in protective bacteria can also favor the proliferation of opportunistic microorganisms, particularly those responsible for mycoses.

The combination of probiotic and antibiotic is then part of an approach to support digestive comfort. It is not about replacing the antibiotic, which is essential in managing the infection, but about supporting the body during this period of vulnerability.

Probiotics, defined as living microorganisms which, when administered in adequate amounts, confer a health benefit on the host, can contribute to the balance of the intestinal flora. In the context of a probiotic and antibiotic combination, they help maintain a more stable intestinal environment.

Their mechanism of action relies on several axes. Some strains temporarily occupy the ecological space left vacant by the decrease in commensal bacteria. Others interact with the intestinal mucosa and contribute to the modulation of the local immune system. Finally, some participate in the production of beneficial metabolites from fermentation.

In an expert nutricosmetic approach, the quality of a food supplement is based on the precise identification of strains, their resistance to gastric acidity, and a guaranteed number of Colony Forming Units (CFUs) at the expiration date. These technical criteria are decisive for optimizing the probiotic and antibiotic complementarity.

The choice of microorganisms is crucial in a probiotic and antibiotic strategy, as not all strains have the same level of scientific validation or the same functional properties during antibiotic therapy.

Not all strains have the same properties. In the probiotic and antibiotic context, some have been the subject of specific clinical studies. Saccharomyces boulardii, a probiotic yeast, is recognized for its natural resistance to the action of antibiotics. Its eukaryotic structure allows it not to be affected by antibacterial molecules.

Lactobacillus rhamnosus GG is also widely documented. Randomized controlled trials have evaluated its benefit in supporting transit during antibiotic therapy, particularly in children and adults. The complete identification of the strain, including the precise denomination, is a guarantee of scientific rigor.

Thus, in a probiotic and antibiotic strategy, prioritizing clearly identified and clinically validated strains strengthens the consistency of the protocol.

The question of choosing between multi-strain probiotics and mono-strain probiotics arises frequently. Multi-strain formulas combine several complementary microorganisms, capable of acting on different physiological mechanisms.

In the context of a probiotic and antibiotic duo, a multi-strain formula can offer interesting functional diversity. It can include strains of Lactobacillus, Bifidobacterium, and sometimes yeasts such as Saccharomyces boulardii. This diversity can contribute to a more global approach to intestinal imbalance.

However, relevance depends on the individual context, the type of antibiotic, and digestive sensitivity. The essential remains technological quality, strain stability, and the number of CFUs guaranteed at expiration.

Diarrhea is one of the most studied situations in relation to the probiotic and antibiotic combination. Several meta-analyses have highlighted the benefit of certain specific strains to support transit during antibiotic therapy.

Saccharomyces boulardii and Lactobacillus rhamnosus GG are among the most documented. Their action appears to be linked to the modulation of the intestinal barrier and competition with opportunistic microorganisms.

It is important to emphasize that these supplements are not a substitute for medical advice. In case of persistent or severe symptoms, consultation is necessary.

The effectiveness of a probiotic and antibiotic combination depends not only on the choice of strains but also on appropriate administration methods to optimize their viability and their interaction with the intestinal microbiota.

In a probiotic and antibiotic strategy, timing is crucial. It is generally advisable to space out the intake of the probiotic supplement from the antibiotic by two to three hours. This precaution limits the direct exposure of bacterial strains to the antibacterial molecule.

This organization optimizes the viability of ingested microorganisms. Formulations resistant to gastric acidity or microencapsulated can also improve their survival until the intestine.

The complementarity of probiotics and antibiotics does not stop with the last antibiotic pill. The post-treatment period is often when the intestinal microbiota remains most vulnerable. It is recommended to continue taking probiotic supplements for 7 to 14 days after the end of treatment. This duration helps support the rebalancing dynamics of the intestinal flora.

Dosage is expressed in CFUs, or Colony Forming Units. In the context of probiotics and antibiotics, dosages ranging from a few billion to several tens of billions of CFUs per day are frequently used in studies. The guarantee of the number of CFUs at the expiration date is a major quality criterion. This technical requirement reflects the seriousness of the formulation and is part of the scientific approach advocated by Biocyte.

Probiotic supplements exist in different forms. Gastro-resistant capsules protect the strains from gastric acidity. Liquid forms or sachets are sometimes adapted for specific populations.

The choice of form contributes to adherence to the probiotic and antibiotic protocol, an essential condition for its functional effectiveness.

The combination of probiotic and antibiotic can contribute to maintaining digestive comfort, modulating the intestinal immune system, and more gradual recovery of bacterial diversity.

Clinical studies have shown a reduction in the incidence of diarrhea in subjects receiving certain specific strains. Other studies suggest participation in the overall balance of the intestinal microbiota after treatment.

The time needed for the intestinal microbiota to rebalance varies depending on the type of antibiotic, the duration of treatment, age, and diet. Some studies indicate a gradual return to a composition close to the initial state within a few weeks, while others show that some species may take longer to re-establish themselves.

In this phase, the probiotic and antibiotic combination, extended after treatment, can help support this natural dynamic.

• Hempel S. et al., Probiotics for the prevention and treatment of antibiotic-associated diarrhea: JAMA, 2012.
• McFarland L.V., Systematic review and meta-analysis of Saccharomyces boulardii in adult patients, World J Gastroenterol, 2010.
• Szajewska H. et al., Lactobacillus rhamnosus GG for preventing antibiotic-associated diarrhea in children, Aliment Pharmacol Ther, 2009.
• Langdon A. et al., The effects of antibiotics on the microbiome, Genome Medicine, 2016.
• Suez J. et al., Post-antibiotic gut mucosal microbiome reconstitution, Cell, 2018.